Norbert Brüggemann

Norbert Brüggemann

Universität zu Lübeck

H-index: 47

Europe-Germany

About Norbert Brüggemann

Norbert Brüggemann, With an exceptional h-index of 47 and a recent h-index of 33 (since 2020), a distinguished researcher at Universität zu Lübeck,

His recent articles reflect a diverse array of research interests and contributions to the field:

Levodopa Impairs the Energy Metabolism of the Basal Ganglia In Vivo

Large‐Scale Screening: Phenotypic and Mutational Spectrum in Isolated and Combined Dystonia Genes

Creative thinking and cognitive estimation in Parkinson’s disease

Aβ38 and Aβ43 do not differentiate between Alzheimer's disease and cerebral amyloid angiopathy

Stability of Mosaic Divergent Repeat Interruptions in X‐Linked Dystonia‐Parkinsonism

Recommendations for optimal interdisciplinary management and healthcare settings for patients with rare neurological diseases

RFC1 and FGF14 Repeat Expansions in Serbian Patients with Cerebellar Ataxia

Bilateral vestibulopathy in RFC1-positive CANVAS is distinctly different compared to FGF14-linked spinocerebellar ataxia 27B

Norbert Brüggemann Information

University

Position

Department of Neurology Institute of Neurogenetics Germany

Citations(all)

6816

Citations(since 2020)

3878

Cited By

4108

hIndex(all)

47

hIndex(since 2020)

33

i10Index(all)

144

i10Index(since 2020)

114

Email

University Profile Page

Universität zu Lübeck

Google Scholar

View Google Scholar Profile

Top articles of Norbert Brüggemann

Title

Journal

Author(s)

Publication Date

Levodopa Impairs the Energy Metabolism of the Basal Ganglia In Vivo

Annals of Neurology

Jannik Prasuhn

Tanja Schiefen

Theresia Güber

Julia Henkel

Jan Uter

...

2024/2/17

Large‐Scale Screening: Phenotypic and Mutational Spectrum in Isolated and Combined Dystonia Genes

Movement Disorders

Mirja Thomsen

Katrin Marth

Sebastian Loens

Judith Everding

Johanna Junker

...

2024/1/12

Creative thinking and cognitive estimation in Parkinson’s disease

Neurological research and practice

Marcus Heldmann

Celia Rinckens

Norbert Brüggemann

Mohamed Al-Khaled

Thomas F Münte

2024/2/15

Aβ38 and Aβ43 do not differentiate between Alzheimer's disease and cerebral amyloid angiopathy

Annals of Clinical and Translational Neurology

Justina Dargvainiene

Ulf Jensen‐Kondering

Benjamin Bender

Daniela Berg

Norbert Brüggemann

...

2024/1/7

Stability of Mosaic Divergent Repeat Interruptions in X‐Linked Dystonia‐Parkinsonism

Movement Disorders

Joshua Laß

Theresa Lüth

Kathleen Schlüter

Susen Schaake

Björn‐Hergen Laabs

...

2024/4/14

Recommendations for optimal interdisciplinary management and healthcare settings for patients with rare neurological diseases

Orphanet Journal of Rare Diseases

Holm Graessner

Carola Reinhard

Tobias Bäumer

Annette Baumgärtner

Knut Brockmann

...

2024/2/13

RFC1 and FGF14 Repeat Expansions in Serbian Patients with Cerebellar Ataxia

Movement Disorders Clinical Practice

Andona Milovanović

Nataša Dragaševic‐Mišković

Mirja Thomsen

Max Borsche

Frauke Hinrichs

...

2024/3/15

Bilateral vestibulopathy in RFC1-positive CANVAS is distinctly different compared to FGF14-linked spinocerebellar ataxia 27B

Journal of Neurology

Max Borsche

Mirja Thomsen

David J Szmulewicz

Bente Lübbers

Frauke Hinrichs

...

2024/2

Neuroenergetic Changes in Patients with X‐Linked Dystonia‐Parkinsonism and Female Carriers

Movement Disorders Clinical Practice

Jannik Prasuhn

Julia Henkel

Shela Marie Algodon

Jan Uter

Raymond L Rosales

...

2024/2/25

Longitudinal predictors of health-related quality of life in isolated dystonia

Journal of neurology

Johanna Junker

James Hall

Brian D Berman

Marie Vidailhet

Emmanuel Roze

...

2024/2

Treatabolome DB: linking gene and variants with treatments for rare diseases

A Corvó

L Matalonga

C Hernandez-Ferrer

R Thompson

L Carmody

...

2023/4/24

Embracing monogenic Parkinson's disease: the MJFF Global Genetic PD cohort

Movement Disorders

Eva‐Juliane Vollstedt

Susen Schaake

Katja Lohmann

Shalini Padmanabhan

Alexis Brice

...

2023/2

Clinical, serological and genetic predictors of response to immunotherapy in anti-IgLON5 disease

Brain

Thomas Grüter

Franziska E Möllers

Anja Tietz

Justina Dargvainiene

Nico Melzer

...

2023/2/1

Characterizing mixed location hemorrhages/microbleeds with CSF markers

International Journal of Stroke

Ulf Jensen-Kondering

Nils G Margraf

Caroline Weiler

Walter Maetzler

Justina Dargvainiene

...

2023/7

Isolated lingual dystonia as a presenting symptom of X-linked dystonia parkinsonism

Parkinsonism & Related Disorders

D Dakay

G Saranza

Z Leonardo

N Brüggemann

A Westenberger

2023/8/1

Characterization of the pathogenic α-Synuclein Variant V15A in Parkinson´ s disease

npj Parkinson's Disease

Sokhna Haissatou Diaw

Max Borsche

Linn Streubel-Gallasch

Marija Dulovic-Mahlow

Julia Hermes

...

2023/10/30

Not to Miss: Intronic Variants, Treatment, and Review of the Phenotypic Spectrum in VPS13D-Related Disorder

Martje G Pauly

Norbert Brüggemann

Stephanie Efthymiou

Anne Grözinger

Sokhna Haissatou Diaw

...

2023/1/18

Frequency of non-motor symptoms in Parkinson's disease patients carrying the E326K and T369M GBA risk variants

Parkinsonism & Related Disorders

Tatiana Usnich

Maria Olmedillas

Nathalie Schell

Jefri J Paul

Filipa Curado

...

2023/2/1

POLG2-Linked Mitochondrial Disease: Functional Insights from New Mutation Carriers and Review of the Literature

Max Borsche

Marija Dulovic-Mahlow

Hauke Baumann

Sinem Tunc

Theresa Lüth

...

2023/4/22

Impact of the Dopamine System on Long‐Term Cognitive Impairment in Parkinson Disease: An Exploratory Study

Movement Disorders Clinical Practice

Daniel Weintraub

Marina Picillo

Hyunkeun Ryan Cho

Chelsea Caspell‐Garcia

Cornelis Blauwendraat

...

2023/6

See List of Professors in Norbert Brüggemann University(Universität zu Lübeck)